Work

Association Between a National Insurer’s Pay-for-Performance Program for Oncology and Changes in Prescribing of Evidence-Based Cancer Drugs and Spending

Year: 2020

Type: article

Study design: Observational Study

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.20.00890

Authors: Justin E. Bekelman, Atul Gupta, Ezra Fishman, David Debono, Michael J. Fisch, Ying Liu, Gosia Sylwestrzak, John Barron, Amol S. Navathe

Institutions: Abramson Cancer Center, Leonard Davis Institute of Health Economics, University of Pennsylvania, National Committee for Quality Assurance, Anthem (United States), The University of Texas MD Anderson Cancer Center, Carelon Research (United States)

Language: English

Topic: Healthcare Policy and Management

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3028716286

FWCI: 1.699

Cites: 23

Cited by: 15

Related to: 10